Steven M Larson Selected Research

6- amino- 8- ((6- iodo- 1,3- benzodioxol- 5- yl)thio)- N- (1- methylethyl)- 9H-purine-9-propanamine

10/2020	First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer.
3/2016	Radiosynthesis of the iodine-124 labeled Hsp90 inhibitor PU-H71.
9/2011	Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven M Larson Research Topics

Disease

130	Neoplasms (Cancer) 01/2022 - 01/2002
52	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2002
23	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2003
17	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 11/2002
10	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 07/2003
8	Breast Neoplasms (Breast Cancer) 01/2020 - 05/2006
8	Neuroblastoma 01/2020 - 03/2003
8	Lymphoma (Lymphomas) 05/2016 - 02/2003
6	Rectal Neoplasms (Rectal Cancer) 08/2013 - 07/2002
5	Melanoma (Melanoma, Malignant) 09/2017 - 07/2011
4	Papillary Thyroid Cancer 06/2013 - 12/2004
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2011 - 05/2005
4	Carcinoma (Carcinomatosis) 02/2011 - 07/2003
3	Glioblastoma (Glioblastoma Multiforme) 11/2015 - 10/2012
3	Renal Cell Carcinoma (Grawitz Tumor) 05/2014 - 08/2003
3	Pain (Aches) 02/2014 - 10/2009
3	Kidney Neoplasms (Kidney Cancer) 04/2012 - 01/2003
3	Head and Neck Neoplasms (Head and Neck Cancer) 10/2008 - 05/2005
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2003 - 01/2002
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 11/2010
2	Hepatocellular Carcinoma (Hepatoma) 03/2018 - 02/2017
2	Disease Progression 02/2018 - 02/2003
2	Glioma (Gliomas) 01/2018 - 12/2012
2	Adenocarcinoma 01/2018 - 10/2005
2	Hyponatremia 02/2017 - 02/2016

Drug/Important Bio-Agent (IBA)

28	AntigensIBA 01/2021 - 09/2003
19	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 03/2004
17	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2016 - 01/2002
15	Monoclonal AntibodiesIBA 01/2022 - 08/2002
15	Pharmaceutical PreparationsIBA 01/2021 - 02/2005
15	AntibodiesIBA 01/2020 - 09/2003
12	Radioisotopes (Radionuclides)IBA 01/2021 - 02/2002
12	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2005
10	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2021 - 05/2006
8	IodineIBA 01/2022 - 10/2006
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2003
8	Biological ProductsIBA 11/2020 - 01/2002
8	Phosphotransferases (Kinase)IBA 11/2020 - 05/2005
8	Prostate-Specific Antigen (Semenogelase)IBA 01/2020 - 01/2002
8	Immunoglobulin G (IgG)IBA 01/2020 - 10/2005
7	procaine isothiocyanate (PRIT)IBA 01/2022 - 07/2014
7	Neoplasm Antigens (Tumor Antigens)IBA 01/2021 - 10/2005
6	LigandsIBA 01/2021 - 09/2007
6	EnzymesIBA 01/2017 - 12/2005
5	Trastuzumab (Herceptin)FDA Link 06/2019 - 07/2003
5	Thyroglobulin FDA Link 01/2019 - 12/2004
4	AcidsIBA 01/2021 - 01/2006
4	RadiopharmaceuticalsIBA 02/2014 - 11/2004
4	Glucose (Dextrose)FDA LinkGeneric 08/2011 - 04/2004
4	Deoxyglucose (2 Deoxy D glucose)IBA 02/2006 - 06/2002
3	lintuzumabIBA 01/2022 - 08/2002
3	omburtamab I-131IBA 01/2022 - 12/2019
3	Thyrotropin Alfa FDA LinkGeneric 01/2022 - 12/2004
3	Iodine-124IBA 01/2022 - 01/2008
3	Peptides (Polypeptides)IBA 01/2021 - 05/2004
3	IsotopesIBA 01/2021 - 08/2002
3	6- amino- 8- ((6- iodo- 1,3- benzodioxol- 5- yl)thio)- N- (1- methylethyl)- 9H-purine-9-propanamineIBA 10/2020 - 09/2011
3	Chimeric Antigen ReceptorsIBA 01/2020 - 09/2007
3	Immunoconjugates (Immunoconjugate)IBA 11/2019 - 12/2007
3	Indicators and Reagents (Reagents)IBA 11/2019 - 10/2013
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 05/2016
3	Dihydrotestosterone (Androstanolone)IBA 01/2019 - 11/2004
3	Hormones (Hormone)IBA 01/2019 - 01/2002
3	enzalutamideIBA 02/2018 - 06/2011
3	Dextrans (Dextran)FDA Link 01/2018 - 02/2014
3	AndrogensIBA 11/2016 - 10/2009
3	IodidesIBA 11/2016 - 04/2008
3	StreptavidinIBA 07/2014 - 01/2006
3	ThymidineIBA 12/2013 - 09/2006
3	arginine deiminaseIBA 12/2013 - 02/2012
3	tanespimycin (17AAG)IBA 04/2012 - 06/2004
3	Therapeutic UsesIBA 04/2008 - 07/2006
2	VemurafenibIBA 01/2022 - 01/2019
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022 - 11/2015
2	Dasatinib (BMS 354825)FDA Link 11/2020 - 12/2012
2	RNA (Ribonucleic Acid)IBA 01/2020 - 08/2011
2	HaptensIBA 01/2020 - 01/2018
2	Technetium Tc 99m MedronateIBA 01/2019 - 12/2010
2	Testosterone (Sustanon)FDA Link 01/2019 - 03/2004
2	Kallikreins (Kallikrein)IBA 01/2019 - 11/2016
2	codrituzumabIBA 03/2018 - 02/2017
2	Iodine-131IBA 01/2017 - 07/2007
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017 - 12/2011
2	J591 monoclonal antibodyIBA 12/2016 - 05/2014
2	Liposomes (Liposome)IBA 12/2016 - 02/2011
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2016 - 05/2006
2	8H9 monoclonal antibodyIBA 12/2015 - 10/2005
2	ErbB Receptors (EGF Receptor)IBA 11/2015 - 02/2011
2	Coloring Agents (Dyes)IBA 10/2014 - 07/2011

Therapy/Procedure

70	Therapeutics 01/2022 - 01/2002
26	Castration 01/2022 - 07/2008
24	Radioimmunotherapy 01/2022 - 02/2003
17	Drug Therapy (Chemotherapy) 01/2018 - 01/2002
12	Radiotherapy 07/2019 - 01/2002
8	Precision Medicine 01/2021 - 04/2012
5	Aftercare (After-Treatment) 01/2020 - 05/2006
4	Immunotherapy 03/2018 - 08/2002
3	Prostatectomy (Retropubic Prostatectomy) 05/2014 - 10/2004
3	Neoadjuvant Therapy 08/2013 - 04/2012
3	Thyroidectomy 06/2013 - 11/2002